Retail Revenues was Curaleaf Holdings’s largest product and service line in fiscal 2025, bringing in $922.58M of $1.27B (73%).
| Product and Service | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Retail Revenues | $1.00B | $1.10B | $1.03B | $922.58M | |
| Retail Revenue | — | — | — | — | |
| Wholesale Revenues | $269.04M | $243.61M | $295.57M | $332.24M | |
| Wholesale Revenue | — | — | — | — | |
| Management Fee Income | $4.84M | $5.85M | $5.97M | $13.31M | |
| Total | $1.28B | $1.35B | $1.33B | $1.27B |
Curaleaf Holdings brought in $1.27B from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 5.0% from $1.33B in fiscal 2024. Retail Revenues was the largest at $922.58M (72.8%), ahead of Wholesale Revenues at $332.24M (26.2%) and Management Fee Income at $13.31M (1.0%).
Compared with fiscal 2024, Wholesale Revenues grew 12.4% to $332.24M, while Retail Revenues fell 10.7% to $922.58M. From fiscal 2022 to 2025, combined revenue from these lines fell from $1.28B to $1.27B, a compound annual decline of 0.2%. Retail Revenues' share of the total fell from 78.5% to 72.8%.
Domestic was Curaleaf Holdings’s largest segment in fiscal 2025, bringing in $1.10B of $1.27B (86%).
| Segment | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Domestic | $1.24B | $1.29B | $1.23B | $1.10B | |
| International | $34.43M | $61.01M | $105.55M | $172.48M | |
| Total | $1.28B | $1.35B | $1.33B | $1.27B |
Curaleaf Holdings brought in $1.27B from its two segments in fiscal 2025, the year ended December 31, 2025. That was down 5.0% from $1.33B in fiscal 2024. Domestic was the largest at $1.10B (86.4%), ahead of International at $172.48M (13.6%).
Compared with fiscal 2024, International grew 63.4% to $172.48M, while Domestic fell 10.8% to $1.10B. From fiscal 2022 to 2025, combined revenue from these segments fell from $1.28B to $1.27B, a compound annual decline of 0.2%. Domestic's share of the total fell from 97.3% to 86.4%.
Previously Reported was Curaleaf Holdings’s largest revenue line in fiscal 2021, bringing in $1.21B of $1.20B (101%).
| Revision of Prior Period | FY 2020 | FY 2021 |
|---|---|---|
| Previously Reported | $626.64M | $1.21B |
| Adjustment | — | -$13.67M |
| Total | $626.64M | $1.20B |
Curaleaf Holdings brought in $1.20B from its two revenue lines in fiscal 2021, the year ended December 31, 2021. Curaleaf Holdings regrouped these revenue lines after fiscal 2020, so the total does not compare directly with that year's $626.64M. Previously Reported was the largest at $1.21B (101.1%).
Curaleaf Holdings began breaking out Adjustment in fiscal 2021, when it brought in -$13.67M. The total is net of Adjustment, which took $13.67M off revenue in fiscal 2021.
Curaleaf Holdings (CURLF) reports its revenue by product and service, by segment and by revision of prior period. In fiscal 2025, Retail Revenues was its largest product and service line, bringing in $922.58M (72.8% of the total), followed by Wholesale Revenues at $332.24M (26.2%).
Retail Revenues was Curaleaf Holdings' largest product and service line in fiscal 2025, bringing in $922.58M, or 72.8% of the $1.27B total across its three product and service lines.
Domestic was Curaleaf Holdings' largest segment in fiscal 2025, bringing in $1.10B, or 86.4% of the $1.27B total across its two segments.
Previously Reported was Curaleaf Holdings' largest revenue line in fiscal 2021, bringing in $1.21B, or 101.1% of the $1.20B total across its two revenue lines.
Wholesale Revenues grew faster than Retail Revenues in fiscal 2025, up 12.4% from $295.57M to $332.24M. Retail Revenues fell 10.7% to $922.58M.
Every figure comes from Curaleaf Holdings' annual financial filings, as reported. Each line keeps the name Curaleaf Holdings gives it, and years follow its fiscal calendar.
Curaleaf Holdings' revenue by product and service goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.